High levels of a blood protein called clusterin are linked to the development of Alzheimer's disease, scientists said on Monday -- a finding which could pave the way for doctors to detect the disease before it takes hold.
Researchers from the Institute of Psychiatry at King's College London said that while doctors are around 5 years away from being able to use the discovery for a test to identify future Alzheimer's sufferers, it was a big step along the way.
Alzheimer's is the most common form of dementia -- a brain-wasting condition that affects around 35 million people around the world -- and despite decades of research, doctors still have few effective weapons against it.(Read entire article)
Scientists have identified a protein that could be an early indicator for Alzheimer's disease, it emerged today.
Researchers found that higher concentrations of clusterin, a protein in the blood plasma, appear to be associated with the development, severity and progression of the condition.
It is hoped the breakthrough could lead to the development of a simple blood test for detecting Alzheimer's, one of the most common forms of dementia in the UK. (Read entire article)